The metabolic fate of S-methyl-C14, ferf-butyl-C14, and N-methyl-C14 Temik [2-methyl-2-(methylthio)propionaldehyde 0-(methylcarbamoyl)oxime] was investigated in the rat. The over-all recovery of the S-methyl, ferf-butyl, and N-methyl label was, respectively, 95, 96 and 72% of the doses. Tissue residues (8 to 10% of the dose) were found only in the case of N-methyl labeled Temik. Seventy per cent of an oral dose of Temik was excreted as 2-methyl-2-(methylsulfinyl)propionaldehyde oxime and 2methyl-2-(methylsulfinyl)propionaldehyde 0-(methylcarbamoyl)oxime.The remaining metabolites appeared to be acids formed by further oxidation of the oxime. In conjunction with the metabolic studies, in vivo cholinesterase depression and recovery curves were obtained with plasma, red blood cells, and brain. At an oral dose of 0.33 mg. per kg., the cholinesterase activity of Temik-treated rats recovered from inhibition two hours prior to the rats treated with 2-methyl-2-(methylsulfinyl)propionaldehyde O-(methylcarbarnoyl)oxime.